Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Northwest Biotherapeutics (NWBO) Other Accumulated Expenses: 2014-2017

Historic Other Accumulated Expenses for Northwest Biotherapeutics (NWBO) over the last 4 years, with Dec 2017 value amounting to $6.2 million.

  • Northwest Biotherapeutics' Other Accumulated Expenses changed negligibly% to $6.2 million in Q3 2018 from the same period last year, while for Sep 2018 it was $6.2 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $6.2 million for FY2017, which is negligibly% changed negligibly from last year.
  • Per Northwest Biotherapeutics' latest filing, its Other Accumulated Expenses stood at $6.2 million for FY2017, which was down 0.00% from $6.2 million recorded in FY2016.
  • Northwest Biotherapeutics' 5-year Other Accumulated Expenses high stood at $6.2 million for FY2014, and its period low was $6.2 million during FY2014.
  • Moreover, its 3-year median value for Other Accumulated Expenses was $6.2 million (2017), whereas its average is $6.2 million.